CNTNAP1 is encoded by the CNTNAP1 gene and is also known as contactin-associated protein 1, Caspr1 and paranodin. It belongs to the Caspr or CATNAP family, which is not only involved in the formation of myelinated axons but also participates in maintaining the stability of adjacent connections. It is one of the five subtypes of CATNAP family proteins, CNTNAP1 (Caspr1), CNTNAP2 (Caspr2), CNTNAP3 (Caspr3), CNTNAP4 (Caspr4) and CNTNAP5 (Caspr5). CNTNAP1 is a single-pass transmembrane protein, was originally identified in neurons by its interaction with contactin protein.
|Basic Information of CNTNAP1|
|Protein Name||Contactin-associated protein 1|
|Aliases||Caspr1, Neurexin IV, Neurexin-4, p190|
|Organism||Homo sapiens (Human)|
CNTNAP1 participates in the formation, differentiation, and proliferation of neurons and astrocytes, and in motor control and cognitive function. CNTNAP1 is localized in the paranodal region and has a role in the generation and maintenance of paranodal junctions in myelinated axons. It forms a complex with contactin and NFASC-155 (NF-155), acts as a barrier between the nodes of Ranvier and internodes, and is involved in the propagation of action potentials and mediation of signal transport. Furthermore, a recent study indicated that CNTNAP1 may mediate the timing of neuron and astrocyte differentiation in neural progenitor cells. The expression of CNTNAP1 has also been associated with certain neurodegenerative diseases and may represent a therapeutic target for treatment. CNTNAP1 is also reported to act as a receptor of bacterial virulence factor IbeA for E. coli penetration through the blood-brain barrier and neuronal CNTNAP1 is exploited by IbeA for the E. coli invasion into neurons leading to neuronal apoptosis.
Fig.1 Proposed model of CNTNAP1(Caspr1) in the intervention of E. coli meningitis (Zhao, 2018).
The results of this article indicate that E. coli exploits Caspr1 (CNTNAP1) as a host receptor for penetration of BBB resulting in meningitis, and that Caspr1 might be a useful target for prevention or therapy of E. coli meningitis.
The authors in this article analyze the relationship between the Caspr family and neurodegenerative diseases, multiple sclerosis, and autoimmune encephalitis and the effects of CNTNAP1 on disease diagnosis and treatment need further investigation.
This article reveals that CNTNAP1 is present in synapses and interacts with AMPA receptors in brain synaptic fractions and coexpression of CNTNAP1 with GluA1 increases the amplitude of glutamate-evoked currents. Hence, CNTNAP1 is a regulator of the trafficking of AMPA receptors to synapses.
This article suggests that CNTNAP1 is an essential component of the paranodal junctions of the peripheral and central nervous systems, and is necessary for the establishment of transverse bands that stabilize paranodal axo-glial junctions.
This article identifies a novel CNTNAP1 homozygous missense mutation (Arg388Pro) in the proband, and both parents were carriers. Molecular modeling suggests that this variant disrupts a β-strand to cause an unstable structure and likely significant changes in protein function.
To obtain the soluble and functional target protein, the versatile Magic™ membrane protein production platform in Creative Biolabs enables many flexible options, from which you can always find a better match for your particular project. Besides, aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-CNTNAP1 antibody development services.
As a forward-looking research institute as well as a leading custom service provider in the field of membrane protein, Creative Biolabs has established a universal membrane protein platform to accomplish numerous challenging projects including generation of many functional membrane proteins. Please feel free to contact us for more information.